Latest Industry Insights

In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.

Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of rare diseases.

Clinical uses of mass spectrometry have historically been limited to specialist facilities. A new solution from Roche automates the entire workflow enabling routine testing laboratories to capitalize on the high sensitivity of mass spectrometry.

Technology Networks had the pleasure of speaking with Dr. Bipin Patel, CEO and founder at electronRx, to learn more about how digital biomarkers could help patients suffering from chronic respiratory disorders.

We interviewed Agilent Technologies at HUPO 2024 to learn about its latest product launch, the Agilent Infinity III LC Series.

Technology Networks spoke with Dr. Mohamed Alameri to explore how population-wide genome initiatives are addressing gaps in genomic data representation and advancing precision medicine in areas such as rare diseases and cancer.

In this article, explore how next-generation protein sequencing is helping to unlock the proteome.

Learn from James Hallam, vice president of the Research, Development and Advanced Testing Business segment at Waters Corporation, about how technological advancements in mass spectrometry are powering new discoveries in omics research.

We sat down with Professor Peter Van Eenoo, director of the Doping Control Laboratory (DoCoLab), part of the University of Ghent, Belgium, to discuss the intricacies of anti-doping testing and the challenges faced in catching sporting cheats.

In this article, Asim Siddiqui explores the emerging ability of proteomics to reveal new biomarkers for disease.